Let’s Make a Deal…on Drug Prices


Let’s Make a Deal…on Drug Prices

November 11, 2021

Let’s Make a Deal…on Drug Prices

Democrats are on the brink of passing a historic set of drug price reforms as part of the Build Back Better Act. How will they impact patients, insurers and the drug industry?


Rachel Sachs, JD, Treiman Professor of Law, Washington University in St. Louis

Find a full transcript of this episode and additional research and reporting on these potential drug price reforms on our website:

Support this type of journalism today, with a gift:

Sign up for our weekly newsletter to see what research health policy experts are reading right now, plus recommendations from our staff:

Follow us on Twitter:

See for privacy and opt-out information.

You may also like

Top Health Podcasts. Delivered to Your Inbox and Eardrums.

Join Our Newsletter

Proudly supported by:

A Diverse Skill Set Peter McCanna is chief executive officer (CEO) at Baylor Scott & White Health, the largest not- for-profit health system in Texas. Through 51 hospitals and more than 1,200 access points, including flagship academic medical centers in Dallas, Fort Worth and Temple, the system offers the full continuum of care, from primary to award-winning specialty care, as well as an array of virtual and in-home services.